- Home
- TCI vs OCGN Comparison
TCI vs OCGN Comparison
Compare TCI & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCI
- OCGN
- Stock Information
- Founded
- TCI 1983
- OCGN 2013
- Country
- TCI United States
- OCGN United States
- Employees
- TCI N/A
- OCGN N/A
- Industry
- TCI Real Estate
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TCI Finance
- OCGN Health Care
- Exchange
- TCI Nasdaq
- OCGN Nasdaq
- Market Cap
- TCI 239.1M
- OCGN 283.3M
- IPO Year
- TCI N/A
- OCGN N/A
- Fundamental
- Price
- TCI $40.27
- OCGN $1.02
- Analyst Decision
- TCI
- OCGN Strong Buy
- Analyst Count
- TCI 0
- OCGN 3
- Target Price
- TCI N/A
- OCGN $6.00
- AVG Volume (30 Days)
- TCI 6.9K
- OCGN 7.5M
- Earning Date
- TCI 08-07-2025
- OCGN 08-01-2025
- Dividend Yield
- TCI N/A
- OCGN N/A
- EPS Growth
- TCI 59.61
- OCGN N/A
- EPS
- TCI 0.92
- OCGN N/A
- Revenue
- TCI $47,452,000.00
- OCGN $4,522,000.00
- Revenue This Year
- TCI N/A
- OCGN N/A
- Revenue Next Year
- TCI N/A
- OCGN N/A
- P/E Ratio
- TCI $45.33
- OCGN N/A
- Revenue Growth
- TCI N/A
- OCGN N/A
- 52 Week Low
- TCI $25.50
- OCGN $0.52
- 52 Week High
- TCI $46.74
- OCGN $1.80
- Technical
- Relative Strength Index (RSI)
- TCI 47.78
- OCGN 49.89
- Support Level
- TCI $41.59
- OCGN $0.91
- Resistance Level
- TCI $42.75
- OCGN $1.16
- Average True Range (ATR)
- TCI 1.10
- OCGN 0.07
- MACD
- TCI -0.68
- OCGN -0.01
- Stochastic Oscillator
- TCI -5.62
- OCGN 40.77
About TCI Transcontinental Realty Investors Inc.
Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").